These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15754446)

  • 1. Coxibs and thrombosis.
    Prescrire Int; 2005 Feb; 14(75):24. PubMed ID: 15754446
    [No Abstract]   [Full Text] [Related]  

  • 2. Coxibs and cardiovascular risk.
    Pijak MR; Huzicka I; Gazdik F
    CMAJ; 2005 Oct; 173(8):852. PubMed ID: 16217096
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse cardiovascular effects of the coxibs.
    Dogné JM; Supuran CT; Pratico D
    J Med Chem; 2005 Apr; 48(7):2251-7. PubMed ID: 15801815
    [No Abstract]   [Full Text] [Related]  

  • 4. [Selective COX-2 inhibitors and cardiovascular risk].
    Meier P; Meyer zu Straten A; Burnier M
    Rev Med Suisse; 2005 Feb; 1(8):543-6, 549-50. PubMed ID: 15794303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rheumatology. Do coxibs pose a cardiovascular risk?].
    So A; de Goumoëns P
    Rev Med Suisse; 2005 Jan; 1(2):168-70, 172. PubMed ID: 15773220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To the heart of the matter: coxibs, smoking, and cardiovascular risk.
    Hermann M; Krum H; Ruschitzka F
    Circulation; 2005 Aug; 112(7):941-5. PubMed ID: 16103251
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problems of cardiovascular toxicity of coxibs and non-selective NSA].
    Forejtová S
    Vnitr Lek; 2006; 52(7-8):677-85. PubMed ID: 16967608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2 controversy: where are we and where do we go from here?
    Khanna D; Khanna PP; Furst DE
    Inflammopharmacology; 2005; 13(4):395-402. PubMed ID: 16354392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COX-2 inhibitors and cardiovascular risk.
    Funk CD; FitzGerald GA
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):470-9. PubMed ID: 18030055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.
    Vardeny O; Solomon SD
    Cardiol Clin; 2008 Nov; 26(4):589-601. PubMed ID: 18929233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Undesired effects of NSAIDS and coxibs].
    Fauler J
    MMW Fortschr Med; 2005 Aug; 147(31-32):31-5. PubMed ID: 16128194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coxibs and cardiovascular risk.
    Allen MJ; McLean-Veysey P; Fleming I
    CMAJ; 2005 Oct; 173(8):853. PubMed ID: 16217098
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclooxygenase inhibition and cardiovascular risk.
    Antman EM; DeMets D; Loscalzo J
    Circulation; 2005 Aug; 112(5):759-70. PubMed ID: 16061757
    [No Abstract]   [Full Text] [Related]  

  • 14. [Insights and views about cardiovascular safety of COX2 inhibitors].
    Wallentin L
    Lakartidningen; 2005 Feb 28-Mar 6; 102(9):666, 668, 671. PubMed ID: 15804041
    [No Abstract]   [Full Text] [Related]  

  • 15. Does the pro-hypertensive effect of cyclooxygenase-2 inhibitors account for the increased risk in cardiovascular disease?
    Messerli FH; Sichrovsky T
    Am J Cardiol; 2005 Sep; 96(6):872-3. PubMed ID: 16169380
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is a further editorial on coxibs needed?].
    Bergmann JF; Champion K; Mouly S; Mahé I
    Presse Med; 2005 Jun; 34(10):699-700. PubMed ID: 16026121
    [No Abstract]   [Full Text] [Related]  

  • 17. COX-2 inhibitors--second, do some good.
    Harrison A
    N Z Med J; 2005 Apr; 118(1212):U1395. PubMed ID: 15806191
    [No Abstract]   [Full Text] [Related]  

  • 18. COX-2 inhibitors--first, do no harm.
    Weatherall M; Aldington S; Shirtcliffe P; Caldwell B; Beasley R
    N Z Med J; 2005 Mar; 118(1211):U1359. PubMed ID: 15778758
    [No Abstract]   [Full Text] [Related]  

  • 19. Comment on: Musculoskeletal pain is associated with a long-term increased risk of cancer and cardiovascular-related mortality.
    Kittisupamongkol W
    Rheumatology (Oxford); 2009 May; 48(5):595; author reply 595. PubMed ID: 19258376
    [No Abstract]   [Full Text] [Related]  

  • 20. Does celecoxib use increase the risk of cardiovascular events?
    Oviedo JA; Schroy PC
    Gastroenterology; 2005 Oct; 129(4):1348-50. PubMed ID: 16230088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.